Psychiatry and Neurology, Neurology · Boston, MA
NPI
1306827241
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
15 Parkman St, Wac 836
Boston, MA, 02114
Phone (617) 724-1873
Groups this clinician bills Medicare through
Medicare paid, 2024
$7,066
54 services
Medicare patients, 2024
35
Average age 68
Drug cost, 2024
$3.4M
491 prescriptions
Company payments, 2025
$2,861
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Merit E Cudkowicz was code 99215 (office e&m - established), 32 times for 22 patients. In total Merit E Cudkowicz billed 54 services in 5 codes, and Medicare paid $7,066.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 32 | 22 | $146.06 | $4,674 |
| 99214 Office E&M - Established | Office | 15 | 11 | $91.07 | $1,366 |
By year: 2022 $7,450 for 56 services; 2023 $8,871 for 72 services; 2024 $7,066 for 54 services.
Medicare prescription drug claims, 2024
In 2024, the drug Merit E Cudkowicz prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 186 prescriptions and refills. In total Merit E Cudkowicz wrote 491 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 186 | 186 | 22 | $2.6M |
| Riluzole Generic | 89 | 163 | 22 | $24K |
| Nuedexta Dextromethorphan Hbr/Quinidine | 61 | 97 | 13 | $149K |
| Relyvrio Sod Phenylbutyrat/Taurursodiol | 42 | 42 | 20 | $544K |
| Teglutik Riluzole | 23 | 23 | Under 11 | $87K |
| Lovastatin Generic | 22 | 43 | Under 11 | $239 |
Brand drugs: 291 claims; generic drugs: 172 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Merit E Cudkowicz $2,861 ($2,861 in general payments such as food, travel and fees) from 5 companies. The largest payer was BioMarin Pharmaceutical Inc. with $1,116.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.